BioCentury | May 16, 2011
Company News

Biocoll GmbH, Genfit, University of Freiburg deal

...began in 2007 and resulted in the successful identification of potential compounds for the receptor. Biocoll...
BioCentury | Nov 10, 2003
Company News

GenSci OrthoBiologics Inc., Osteotech musculoskeletal news

...As planned, OSTE will recognize the entire settlement this quarter. GenSci OrthoBiologics Inc. , Toronto, Ontario...
...OrthoBiologics Inc. , Toronto, Ontario Osteotech Inc. (OSTE), Eatontown, N.J. Business: Musculoskeletal OSTE received from GenSci...
...of the $7.5 million awarded to OSTE in a settlement agreement resolving OSTE's claims against GenSci...
BioCentury | Nov 3, 2003
Company News

GenSci OrthoBiologics Inc., IsoTis S.A. deal

...million. The company also expects to reach cash flow break-even and become profitable during 2005. GenSci...
BioCentury | Oct 20, 2003
Company News

GenSci OrthoBiologics Inc., IsoTis S.A. deal

...merger will be effective Oct. 27, and the new company will be called IsoTis OrthoBiologics. GenSci...
BioCentury | Oct 6, 2003
Finance

Restructuring watch

...on orthobiologics; plans to discontinue or spin off cell biology programs. ISON is merging with GenSci...
BioCentury | Sep 29, 2003
Company News

GenSci, IsoTis S.A. management update

...& sales for North America and NAFTA countries for the combined company, from manager of GenSci's...
BioCentury | Sep 8, 2003
Company News

IsoTis S.A. dermatology, musculoskeletal news

...by 29% to 60 from 85. ISON is merging with GenSci OrthoBiologics, a subsidiary of GenSci Regeneration Sciences Inc....
BioCentury | Aug 11, 2003
Company News

GenSci, IsoTis S.A. deal

...component of $600,000 to cover transaction costs. The deal is expected to close in October. GenSci Regeneration Sciences Inc....
BioCentury | Aug 11, 2003
Finance

Ebb & Flow

...$157 million). Biosurgery company IsoTis (SWX:ISON; Euronext:ISON) gained CHF0.25 (12%) to CHF2.30 on Tuesday, after GenSci...
BioCentury | Jun 30, 2003
Company News

GenSci, IsoTis S.A. deal

...maxillofacial reconstruction. GNS will receive an upfront payment and is eligible for milestones and royalties. GenSci Regeneration Sciences Inc....
Items per page:
1 - 10 of 47
BioCentury | May 16, 2011
Company News

Biocoll GmbH, Genfit, University of Freiburg deal

...began in 2007 and resulted in the successful identification of potential compounds for the receptor. Biocoll...
BioCentury | Nov 10, 2003
Company News

GenSci OrthoBiologics Inc., Osteotech musculoskeletal news

...As planned, OSTE will recognize the entire settlement this quarter. GenSci OrthoBiologics Inc. , Toronto, Ontario...
...OrthoBiologics Inc. , Toronto, Ontario Osteotech Inc. (OSTE), Eatontown, N.J. Business: Musculoskeletal OSTE received from GenSci...
...of the $7.5 million awarded to OSTE in a settlement agreement resolving OSTE's claims against GenSci...
BioCentury | Nov 3, 2003
Company News

GenSci OrthoBiologics Inc., IsoTis S.A. deal

...million. The company also expects to reach cash flow break-even and become profitable during 2005. GenSci...
BioCentury | Oct 20, 2003
Company News

GenSci OrthoBiologics Inc., IsoTis S.A. deal

...merger will be effective Oct. 27, and the new company will be called IsoTis OrthoBiologics. GenSci...
BioCentury | Oct 6, 2003
Finance

Restructuring watch

...on orthobiologics; plans to discontinue or spin off cell biology programs. ISON is merging with GenSci...
BioCentury | Sep 29, 2003
Company News

GenSci, IsoTis S.A. management update

...& sales for North America and NAFTA countries for the combined company, from manager of GenSci's...
BioCentury | Sep 8, 2003
Company News

IsoTis S.A. dermatology, musculoskeletal news

...by 29% to 60 from 85. ISON is merging with GenSci OrthoBiologics, a subsidiary of GenSci Regeneration Sciences Inc....
BioCentury | Aug 11, 2003
Company News

GenSci, IsoTis S.A. deal

...component of $600,000 to cover transaction costs. The deal is expected to close in October. GenSci Regeneration Sciences Inc....
BioCentury | Aug 11, 2003
Finance

Ebb & Flow

...$157 million). Biosurgery company IsoTis (SWX:ISON; Euronext:ISON) gained CHF0.25 (12%) to CHF2.30 on Tuesday, after GenSci...
BioCentury | Jun 30, 2003
Company News

GenSci, IsoTis S.A. deal

...maxillofacial reconstruction. GNS will receive an upfront payment and is eligible for milestones and royalties. GenSci Regeneration Sciences Inc....
Items per page:
1 - 10 of 47